Skip to main content
. Author manuscript; available in PMC: 2017 Nov 9.
Published in final edited form as: AIDS. 2017 Apr;31(Suppl 1):S61–S68. doi: 10.1097/QAD.0000000000001419

Table 3.

Effect of estimating σinfl2 on uncertainty about epidemic estimates of HIV prevalence and incidence.

HIV prevalence HIV incidence


1990 1995 2000 2005 1990 1995 2000 2005
r-trend model
 CV, no σinfl2 0.19 [0.12–0.23] 0.09 [0.07–0.11] 0.08 [0.05–0.09] 0.06 [0.05–0.09] 0.13 [0.11–0.20] 0.11 [0.09–0.14] 0.11 [0.07–0.15] 0.12 [0.09–0.17]
 CV, σinfl2 estim. 0.26 [0.18–0.39] 0.13 [0.09–0.19] 0.10 [0.07–0.12] 0.07 [0.05–0.09] 0.25 [0.18–0.39] 0.16 [0.13–0.20] 0.13 [0.10–0.19] 0.15 [0.10–0.19]
 Ratio 1.49 [1.26–1.78] 1.32 [1.22–1.68] 1.25 [1.11–1.46] 1.04 [1.01–1.12] 1.52 [1.25–1.94] 1.36 [1.20–1.73] 1.27 [1.06–1.39] 1.11 [1.01–1.31]
r-spline model
 CV, no σinfl2 0.16 [0.12–0.21] 0.08 [0.07–0.10] 0.07 [0.06–0.08] 0.06 [0.05–0.09] 0.12 [0.11–0.16] 0.10 [0.09–0.13] 0.10 [0.08–0.14] 0.12 [0.09–0.16]
 CV, σinfl2 estim. 0.21 [0.16–0.29] 0.12 [0.09–0.17] 0.08 [0.07–0.11] 0.07 [0.05–0.09] 0.17 [0.13–0.23] 0.13 [0.09–0.18] 0.10 [0.08–0.13] 0.12 [0.09–0.18]
 Ratio 1.40 [1.19–1.54] 1.33 [1.17–1.51] 1.18 [1.09–1.29] 1.03 [1.00–1.08] 1.34 [1.11–1.50] 1.21 [1.12–1.40] 1.03 [0.95–1.13] 1.10 [0.98–1.18]
r-spline, no equilibrium prior
 CV, no σinfl2 0.16 [0.12–0.21] 0.09 [0.07–0.11] 0.07 [0.06–0.08] 0.07 [0.05–0.09] 0.12 [0.11–0.16] 0.11 [0.09–0.13] 0.10 [0.07–0.15] 0.13 [0.10–0.18]
 CV, σinfl2 estim. 0.21 [0.17–0.29] 0.13 [0.10–0.16] 0.10 [0.08–0.11] 0.07 [0.06–0.09] 0.17 [0.15–0.23] 0.15 [0.12–0.17] 0.12 [0.09–0.16] 0.15 [0.12–0.22]
 Ratio 1.36 [1.10–1.60] 1.36 [1.18–1.56] 1.23 [1.09–1.35] 1.06 [1.03–1.13] 1.37 [1.15–1.54] 1.29 [1.15–1.43] 1.14 [1.01–1.27] 1.16 [1.09–1.32]

Measured via coefficient of variation (CV) in years 1990, 1995, 2000, and 2005 when estimating σinfl2 versus not. Results are median and interquartile range (IQR) over 40 datasets. CV, coefficient of variation.